Showing 25,261 - 25,280 results of 69,501 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 0.75s Refine Results
  1. 25261

    The position of the boundary between the leading and trailing zones is parameter dependent. by Hildur Knutsdottir (3900343)

    Published 2017
    “…Conversely, increasing <i>F</i><sub>1</sub> (second row) and <i>W</i><sub>0</sub> (third row) results in a decrease in the size of the Wnt domain. Results from the full 3D model after 50 min of simulation time (before the onset of migration).…”
  2. 25262
  3. 25263
  4. 25264

    Methylmercury inhibits prolactin release in a cell line of pituitary origin by L.A.L. Maués (6511835)

    Published 2019
    “…Exposure to methylmercury (0-100 μM) was cytotoxic in a time- and concentration-dependent manner, with an LC50 higher than described for cells of neuronal origin, suggesting GH3B6 cells have a relative resistance. …”
  5. 25265

    Identification of a RORE in the <i>SOX4</i> promoter. by Yongjun Wang (134570)

    Published 2013
    “…Densitometry was used to assess expression and was signal was normalized to tubulin and the normalized relative (to time 0) expression is indicated below the blots. p53 displayed a half-life of 22±6 min (mean±S.E.) in the absence of RORα and a half-life >90 min with RORα overexpressed.…”
  6. 25266

    A linear-nonlinear decoder can detect the flash onset. by Genadiy Vasserman (206694)

    Published 2010
    “…<p><b>A</b>. Stimulus detection error rates using single cell (red stars) and network (blue dots) responses. …”
  7. 25267

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  8. 25268

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  9. 25269

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  10. 25270

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  11. 25271

    Table_1_Effect of a regular consumption of traditional and roasted oat and barley flakes on blood lipids and glucose metabolism–A randomized crossover trial.DOCX by Sarah Reiners (14555423)

    Published 2023
    “…Background<p>Regular consumption of the soluble dietary fiber β-glucan is associated with decreased total cholesterol (TC), low-density lipoprotein (LDL) cholesterol and blood glucose. …”
  12. 25272

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  13. 25273

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  14. 25274

    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  15. 25275

    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

    Published 2024
    “…We also estimated overall spending and costs per patient visit.</p>Results<p>A total of 400 patients were included (17.3% pediatric), with a mean follow-up of 122.1/person-years for adults. …”
  16. 25276
  17. 25277

    A. Evaluation of ROS with various doses of Se and SGG after 1 by Rema Sreenivasan Soumya (464856)

    Published 2013
    “…Fluorescent microscopic images of H9c2 cells stained with DCFDA (20×). (a) Control cells; (b, c, d) cells treated with 5, 25 and 50 nM Se, respectively; (e, f, g) cells treated with 5, 25 and 50 nM of SGG, respectively; (h) The decrease in ROS production with Se and SGG is the sign of non toxicity of particle to cells for longer duration (24 h). …”
  18. 25278
  19. 25279
  20. 25280